These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 22004792

  • 1. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M, Fuentes P, Gilman RH, Gutiérrez AH, Kirwan D, Sheen P.
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [Abstract] [Full Text] [Related]

  • 2. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P, Lozano K, Gilman RH, Valencia HJ, Loli S, Fuentes P, Grandjean L, Zimic M.
    Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
    [Abstract] [Full Text] [Related]

  • 3. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT.
    BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001
    [Abstract] [Full Text] [Related]

  • 4. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.
    Sheen P, Monsalve A, Campos J, Huerta R, Antiparra R, Arteaga H, Duran P, Bueno C, Kirwan DE, Gilman RH, Zimic M.
    J Bacteriol; 2020 Jan 02; 202(2):. PubMed ID: 31636108
    [Abstract] [Full Text] [Related]

  • 5. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y, Zhang J, Cui P, Zhang Y, Zhang W.
    Antimicrob Agents Chemother; 2017 Aug 02; 61(8):. PubMed ID: 28584158
    [Abstract] [Full Text] [Related]

  • 6. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y, Scorpio A, Nikaido H, Sun Z.
    J Bacteriol; 1999 Apr 02; 181(7):2044-9. PubMed ID: 10094680
    [Abstract] [Full Text] [Related]

  • 7. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P, Ferrer P, Gilman RH, López-Llano J, Fuentes P, Valencia E, Zimic MJ.
    Tuberculosis (Edinb); 2009 Mar 02; 89(2):109-13. PubMed ID: 19249243
    [Abstract] [Full Text] [Related]

  • 8. A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Zimic M, Loli S, Gilman RH, Gutierrez A, Fuentes P, Cotrina M, Kirwan D, Sheen P.
    Microb Drug Resist; 2012 Aug 02; 18(4):372-5. PubMed ID: 22372927
    [Abstract] [Full Text] [Related]

  • 9. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.
    BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143
    [Abstract] [Full Text] [Related]

  • 10. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z, Zhang Y.
    Antimicrob Agents Chemother; 1999 Mar 20; 43(3):537-42. PubMed ID: 10049264
    [Abstract] [Full Text] [Related]

  • 11. A quantitative adaptation of the Wayne test for pyrazinamide resistance.
    Meinzen C, Proaño A, Gilman RH, Caviedes L, Coronel J, Zimic M, Sheen P.
    Tuberculosis (Edinb); 2016 Jul 20; 99():41-46. PubMed ID: 27450003
    [Abstract] [Full Text] [Related]

  • 12. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y.
    Antimicrob Agents Chemother; 2000 Mar 20; 44(3):528-32. PubMed ID: 10681313
    [Abstract] [Full Text] [Related]

  • 13. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P, Cabibbe AM, Feuerriegel S, Casali N, Drobniewski F, Rodionova Y, Bakonyte D, Stakenas P, Pimkina E, Augustynowicz-Kopeć E, Degano M, Ambrosi A, Hoffner S, Mansjö M, Werngren J, Rüsch-Gerdes S, Niemann S, Cirillo DM.
    mBio; 2014 Oct 21; 5(5):e01819-14. PubMed ID: 25336456
    [Abstract] [Full Text] [Related]

  • 14. Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.
    Rueda D, Bernard C, Gandy L, Capton E, Boudjelloul R, Brossier F, Veziris N, Zimic M, Sougakoff W.
    Int J Mycobacteriol; 2018 Oct 21; 7(1):16-25. PubMed ID: 29516881
    [Abstract] [Full Text] [Related]

  • 15. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
    Davies AP, Billington OJ, McHugh TD, Mitchison DA, Gillespie SH.
    J Clin Microbiol; 2000 Oct 21; 38(10):3686-8. PubMed ID: 11015384
    [Abstract] [Full Text] [Related]

  • 16. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
    Suzuki Y, Suzuki A, Tamaru A, Katsukawa C, Oda H.
    J Clin Microbiol; 2002 Feb 21; 40(2):501-7. PubMed ID: 11825963
    [Abstract] [Full Text] [Related]

  • 17. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M, Sheen P, Quiliano M, Gutierrez A, Gilman RH.
    Infect Genet Evol; 2010 Mar 21; 10(2):346-9. PubMed ID: 19963078
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity.
    Raynaud C, Lanéelle MA, Senaratne RH, Draper P, Lanéelle G, Daffé M.
    Microbiology (Reading); 1999 Jun 21; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262
    [Abstract] [Full Text] [Related]

  • 19. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y.
    Antimicrob Agents Chemother; 1997 Mar 21; 41(3):540-3. PubMed ID: 9055989
    [Abstract] [Full Text] [Related]

  • 20. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S, Fonseca Lde S, Marsico AG, de Oliveira Vieira GB, Sobral LF, Stehr M, Singh M, Saad MH.
    Infect Genet Evol; 2013 Oct 21; 19():1-6. PubMed ID: 23770140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.